Rice Hall James & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.1M | Sell |
|
|||||
|
2025
Q2 | $14.4M | Sell |
|
|||||
|
2025
Q1 | $11.2M | Sell |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $11M | Sell |
|
|||||
|
2024
Q2 | $12.1M | Buy |
|
|||||
|
2024
Q1 | $12.3M | Sell |
|
|||||
|
2023
Q4 | $21.7M | Sell |
|
|||||
|
2023
Q3 | $14.5M | Sell |
|
|||||
|
2023
Q2 | $21.2M | Sell |
|
|||||
|
2023
Q1 | $16.7M | Sell |
|
|||||
|
2022
Q4 | $15.2M | Buy |
|
|||||
|
2022
Q3 | $8.57M | Sell |
|
|||||
|
2022
Q2 | $7.66M | Buy |
|
|||||
|
2022
Q1 | $11.2M | Buy |
|
|||||
|
2021
Q4 | $10.8M | Sell |
|
|||||
|
2021
Q3 | $8.25M | Sell |
|
|||||
|
2021
Q2 | $12.5M | Sell |
|
|||||
|
2021
Q1 | $14.8M | Buy |
|
|||||
|
2020
Q4 | $14.7M | Sell |
|
|||||
|
2020
Q3 | $11.3M | Buy |
|
|||||
|
2020
Q2 | $9.3M | Sell |
|
|||||
|
2020
Q1 | $8.29M | Buy |
|